Publications by authors named "Lixiang Fu"

Claim this Profile
S
Supergravity separation: An innovative strategy for efficient cleaning and upgrading of coal gasification slag waste.
Hailong Tang, Jingfeng He, Lixiang Fu, Jiahui Zhang, Liangyu Yao

Waste Manag· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Biological Evaluation of New Diphenyl Ether Formylhydrazide Compounds as Potent Inhibitors of Succinate Dehydrogenase.
Bo He, Wang Chen, Lixiang Fu, Mengxu Hu, Zhenxi Xiong

J Agric Food Chem· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanoflower-like NiCoO Composite Graphene Oxide as a Bifunctional Catalyst for Zinc-Air Battery Cathode.
Lixiang Fu, Yifan Yao, Jingling Ma, Zhikang Zhang, Guangxin Wang

Langmuir· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular, morphological and behavioral alterations of zebrafish (Danio rerio) embryos/larvae after clorprenaline hydrochloride exposure.
Binjie Wang, Anli Wang, Chengrui Xu, Zan Tong, Yijing Wang, Lixiang Fu

Food Chem Toxicol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of aerobic and resistance exercises in improving visceral adipose in patients with non-alcoholic fatty liver: a meta-analysis of randomized controlled trials.
Lixiang Fu, Wenyue Zhang, Yupei Ao, Zhongling Zheng, Huaidong Hu

Z Gastroenterol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fentanyl Induces Novel Conditioned Place Preference in Adult Zebrafish, Disrupts Neurotransmitter Homeostasis, and Triggers Behavioral Changes.
Yuanzhao Wu, Anli Wang, Lixiang Fu, Meng Liu, Kang Li

Int J Environ Res Public Health· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The epigallocatechin gallate derivative Y6 reduces the cardiotoxicity and enhances the efficacy of daunorubicin against human hepatocellular carcinoma by inhibiting carbonyl reductase 1 expression.
Huan Zhou, Li-Xiang Fu, Li Li, Yan-Yan Chen, Hong-Qing Zhu

J Ethnopharmacol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The epigallocatechin gallate derivative Y inhibits human hepatocellular carcinoma by inhibiting angiogenesis in MAPK/ERK1/2 and PI3K/AKT/ HIF-1α/VEGF dependent pathways.
Zhi-Hong Liao, Hong-Qing Zhu, Yan-Yan Chen, Run-Li Chen, Li-Xiang Fu

J Ethnopharmacol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Y6, an epigallocatechin gallate derivative, on reversing doxorubicin drug resistance in human hepatocellular carcinoma cells.
Yan Wen, Rui-Qiang Zhao, Yun-Kai Zhang, Pranav Gupta, Li-Xiang Fu

Oncotarget· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis